83 related articles for article (PubMed ID: 21651940)
1. Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells.
Frensing T; Seitz C; Heynisch B; Patzina C; Kochs G; Reichl U
Vaccine; 2011 Sep; 29(41):7125-9. PubMed ID: 21651940
[TBL] [Abstract][Full Text] [Related]
2. High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state.
Seitz C; Frensing T; Höper D; Kochs G; Reichl U
J Gen Virol; 2010 Jul; 91(Pt 7):1754-63. PubMed ID: 20357039
[TBL] [Abstract][Full Text] [Related]
3. Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response.
Seitz C; Isken B; Heynisch B; Rettkowski M; Frensing T; Reichl U
Appl Microbiol Biotechnol; 2012 Jan; 93(2):601-11. PubMed ID: 21915610
[TBL] [Abstract][Full Text] [Related]
4. Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
Brands R; Visser J; Medema J; Palache AM; van Scharrenburg GJ
Dev Biol Stand; 1999; 98():93-100; discussion 111. PubMed ID: 10494962
[TBL] [Abstract][Full Text] [Related]
5. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
9. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation.
Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M
J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284
[TBL] [Abstract][Full Text] [Related]
10. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
11. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
12. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
[TBL] [Abstract][Full Text] [Related]
13. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
[TBL] [Abstract][Full Text] [Related]
14. Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus.
Ueda M; Yamate M; Du A; Daidoji T; Okuno Y; Ikuta K; Nakaya T
Virus Res; 2008 Sep; 136(1-2):91-7. PubMed ID: 18550190
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity.
Wang Y; Xu H; Wu N; Shi H; Wang X; Wang T
New Microbiol; 2010 Oct; 33(4):311-7. PubMed ID: 21213589
[TBL] [Abstract][Full Text] [Related]
16. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells.
Govorkova EA; Matrosovich MN; Tuzikov AB; Bovin NV; Gerdil C; Fanget B; Webster RG
Virology; 1999 Sep; 262(1):31-8. PubMed ID: 10489338
[TBL] [Abstract][Full Text] [Related]
17. Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production.
Liu J; Mani S; Schwartz R; Richman L; Tabor DE
Vaccine; 2010 Feb; 28(5):1285-93. PubMed ID: 19944150
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
Vester D; Rapp E; Gade D; Genzel Y; Reichl U
Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
[TBL] [Abstract][Full Text] [Related]
19. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
Donelan NR; Dauber B; Wang X; Basler CF; Wolff T; García-Sastre A
J Virol; 2004 Nov; 78(21):11574-82. PubMed ID: 15479798
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of strictinin on influenza virus replication.
Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T
Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]